AACR Special Conference Dives Deep Into Tumor Immunology
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
Tag: immunotherapy
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.